Lim S, Beers S, Al-Shamkhani A, Cragg M
Clin Cancer Res. 2023; 30(9):1712-1723.
PMID: 38153346
PMC: 7615925.
DOI: 10.1158/1078-0432.CCR-23-1014.
Song K, Yu J, Li J, Li M, Peng L, Yi P
Viruses. 2023; 15(7).
PMID: 37515271
PMC: 10383485.
DOI: 10.3390/v15071586.
Li P, Jin Y, Zhao R, Xue Z, Ji J
Mol Med Rep. 2022; 26(5).
PMID: 36177915
PMC: 9551409.
DOI: 10.3892/mmr.2022.12864.
Alexander M, Luo Y, Raimondi G, OShea J, Gadina M
Pharmaceuticals (Basel). 2022; 15(1).
PMID: 35056105
PMC: 8779366.
DOI: 10.3390/ph15010048.
Mitra A, Shanthalingam S, Sherman H, Singh K, Canakci M, Torres J
Front Immunol. 2020; 11:735.
PMID: 32457739
PMC: 7221189.
DOI: 10.3389/fimmu.2020.00735.
Insights into CD8 T Cell Activation and Exhaustion from a Mouse Gammaherpesvirus Model.
Sarawar S, Shen J, Dias P
Viral Immunol. 2020; 33(3):215-224.
PMID: 32286179
PMC: 7185348.
DOI: 10.1089/vim.2019.0183.
The Roles of Coinhibitory Receptors in Pathogenesis of Human Retroviral Infections.
Yasuma-Mitobe K, Matsuoka M
Front Immunol. 2018; 9:2755.
PMID: 30538707
PMC: 6277675.
DOI: 10.3389/fimmu.2018.02755.
Biological Activity of Masked Endotoxin.
Schwarz H, Gornicec J, Neuper T, Parigiani M, Wallner M, Duschl A
Sci Rep. 2017; 7:44750.
PMID: 28317862
PMC: 5357793.
DOI: 10.1038/srep44750.
Immune checkpoint receptors in regulating immune reactivity in rheumatic disease.
Ceeraz S, Nowak E, Burns C, Noelle R
Arthritis Res Ther. 2015; 16(5):469.
PMID: 25606596
PMC: 4289356.
DOI: 10.1186/s13075-014-0469-1.
TCR and CD28 activate the transcription factor NF-κB in T-cells via distinct adaptor signaling complexes.
Thaker Y, Schneider H, Rudd C
Immunol Lett. 2014; 163(1):113-9.
PMID: 25455592
PMC: 4286576.
DOI: 10.1016/j.imlet.2014.10.020.
Pivotal roles of T-helper 17-related cytokines, IL-17, IL-22, and IL-23, in inflammatory diseases.
Qu N, Xu M, Mizoguchi I, Furusawa J, Kaneko K, Watanabe K
Clin Dev Immunol. 2013; 2013:968549.
PMID: 23956763
PMC: 3728507.
DOI: 10.1155/2013/968549.
B7 family checkpoint regulators in immune regulation and disease.
Ceeraz S, Nowak E, Noelle R
Trends Immunol. 2013; 34(11):556-63.
PMID: 23954143
PMC: 3821798.
DOI: 10.1016/j.it.2013.07.003.
T cell vaccinology: exploring the known unknowns.
Burchill M, Tamburini B, Pennock N, White J, Kurche J, Kedl R
Vaccine. 2012; 31(2):297-305.
PMID: 23137843
PMC: 3529748.
DOI: 10.1016/j.vaccine.2012.10.096.
Costimulation blockade: current perspectives and implications for therapy.
Kinnear G, Jones N, Wood K
Transplantation. 2012; 95(4):527-35.
PMID: 23129000
PMC: 3580065.
DOI: 10.1097/TP.0b013e31826d4672.
Manipulation of costimulatory molecules by intracellular pathogens: veni, vidi, vici!!.
Khan N, Gowthaman U, Pahari S, Agrewala J
PLoS Pathog. 2012; 8(6):e1002676.
PMID: 22719245
PMC: 3375268.
DOI: 10.1371/journal.ppat.1002676.
Aminoimidazole carboxamide ribonucleotide ameliorates experimental autoimmune uveitis.
Suzuki J, Yoshimura T, Simeonova M, Takeuchi K, Murakami Y, Morizane Y
Invest Ophthalmol Vis Sci. 2012; 53(7):4158-69.
PMID: 22562518
PMC: 3392008.
DOI: 10.1167/iovs.11-9323.
Short-term immunosuppression promotes engraftment of embryonic and induced pluripotent stem cells.
Pearl J, Lee A, Leveson-Gower D, Sun N, Ghosh Z, Lan F
Cell Stem Cell. 2011; 8(3):309-17.
PMID: 21362570
PMC: 3061351.
DOI: 10.1016/j.stem.2011.01.012.
Anti-CD40 monoclonal antibody synergizes with CTLA4-Ig in promoting long-term graft survival in murine models of transplantation.
Gilson C, Milas Z, Gangappa S, Hollenbaugh D, Pearson T, Ford M
J Immunol. 2009; 183(3):1625-35.
PMID: 19592649
PMC: 2828346.
DOI: 10.4049/jimmunol.0900339.
Downregulation of CD40 ligand response in monocytes from sepsis patients.
Sinistro A, Almerighi C, Ciaprini C, Natoli S, Sussarello E, Di Fino S
Clin Vaccine Immunol. 2008; 15(12):1851-8.
PMID: 18945879
PMC: 2593171.
DOI: 10.1128/CVI.00184-08.
PD-1-dependent mechanisms maintain peripheral tolerance of donor-reactive CD8+ T cells to transplanted tissue.
Koehn B, Ford M, Ferrer I, Borom K, Gangappa S, Kirk A
J Immunol. 2008; 181(8):5313-22.
PMID: 18832687
PMC: 2572818.
DOI: 10.4049/jimmunol.181.8.5313.
